Early Phase CRO Solutions
DVCR’s CRO services include project management, data management, biostatistics, monitoring, PK/PD analysis, medical writing as well as site feasibility and management for multi-site trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.
Multi-Site Trials
Data Management
PK/PD Analysis
90-Bed Phase I Unit
Biostatistics
Medical Monitoring
Project Management
Medical Writing
Clinical Monitoring
Early Phase CRO Solutions
At Dr. Vince Clinical Research our CRO services include project management, data management, biostatistics, monitoring, PK/PD analysis, medical writing as well as site feasibility and management for multi-site trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.
Multi-Site Trials
90-Bed Phase I Unit
Project Management
Data Management
Biostatistics
Medical Writing
PK/PD Analysis
Medical Monitoring
Clinical Monitoring
Multi-Site Trials
90-Bed Phase I Unit
Project Management
Data Management
Biostatistics
Medical Writing
PK/PD Analysis
Medical Monitoring
Clinical Monitoring
Human Abuse Potential
Over the last 20 years, the DVCR team has specialized in the design, planning and conduct of HAP studies, with expertise in unique populations, key endpoints and operational complexities.
Acute and Experimental Pain Models
The DVCR team has broad expertise in pain therapeutics led by our Executive Vice President, Scientific Affairs, Lynn R. Webster, MD.
Harm Reduction Tobacco & Nicotine
DVCR operates a 90-bed clinical unit and has a team of experienced professionals that have conducted a large number of tobacco and nicotine studies with numerous types of products.
Human Abuse Potential
Over the last 20 years, the DVCR team has specialized in the design, planning, and conduct of HAP studies, with expertise in unique populations, key endpoints and operational complexities.
Acute and Experimental Pain Models
The DVCR team has broad expertise in pain therapeutics led by our Executive Vice President, Scientific Affairs, Lynn R. Webster, MD.
Tobacco and Nicotine Harm Reduction
DVCR operates a 90-bed clinical unit and has a team of experienced professionals that have conducted a large number of tobacco and nicotine studies with numerous types of products.
WEBINAR
Pharmacy Considerations for Early Phase Trials
WEBINAR
Pharmacy Considerations for Early Phase Trials
Learn key considerations from experts for successfully planning pharmacy activities in early-phase trials.
WEBINAR
Pharmacy Considerations for Early Phase Trials
Learn key considerations from experts for successfully planning pharmacy activities in early-phase trials, such as evaluating equipment and supply needs, developing a pharmacy manual, blinding strategies, preparing suitable placebos, selecting control drugs, identifying vendors and more.
Join the Conversation
Our Multi-Site Model
By combining our robust CRO support services and a network of over 50 strategic site partners across North America, Dr. Vince Clinical Research (DVCR) can now manage multi-site Phase I-III studies in patients, specialty populations and healthy normal volunteers across a diverse range of therapeutic areas and trial designs.
Our model prioritizes sites that leverage these principles to help our sponsors reach their milestones faster.
Site ID and Selection
Quality over quantity is imperative for a successful model as we are not trying to be all things to everyone.
Prioritizing Site Payments
Sites need quicker payments to avoid study delays. This reinforces our collaborative, true partnership approach.
Site Engagement
We are committed to being a true partner, providing sites with essential tools, support, and prioritizing transparent communication and collaboration.
Lead Site ModelTM
DVCR as Lead Site expedites recruitment, mitigates issues, standardizes conduct and data, and provides hands-on training for sites.
Our Multi-Site Model
By combining our robust CRO support services and a network of over 50 strategic site partners across North America, Dr. Vince Clinical Research (DVCR) can now manage multi-site Phase I-III studies in patients, specialty populations and healthy normal volunteers across a diverse range of therapeutic areas and trial designs.
Our model prioritizes sites that leverage these principles to help our sponsors reach their milestones faster.
Site ID and Selection
Quality over quantity is imperative for a successful model as we are not trying to be all things to everyone.
Prioritizing Site Payments
Sites need quicker payments to avoid study delays. This reinforces our collaborative, true partnership approach.
Site Engagement
We are committed to being a true partner, providing sites with essential tools, support, and prioritizing transparent communication and collaboration.
Lead Site ModelTM
DVCR as Lead Site expedites recruitment, mitigates issues, standardizes conduct and data, and provides hands-on training for sites.
“We created a world-class CRO by investing in people, technology and environmental sustainability.”
Bradley D. Vince, D.O. CEO & Chief Medical Officer
